Shares of Sientra, Inc. (NASDAQ:SIEN – Get Rating) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $1.54 and traded as high as $1.70. Sientra shares last traded at $1.57, with a volume of 165,307 shares changing hands.
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on the stock. Maxim Group dropped their price objective on shares of Sientra from $7.00 to $5.00 and set a “buy” rating on the stock in a research note on Friday, March 31st. Craig Hallum cut their price objective on shares of Sientra from $13.00 to $10.00 and set a “buy” rating for the company in a report on Friday, March 31st. Finally, StockNews.com started coverage on shares of Sientra in a research note on Thursday, May 18th. They set a “hold” rating on the stock.
Sientra Trading Down 7.6 %
The business has a 50-day moving average price of $1.54 and a 200-day moving average price of $1.93. The stock has a market cap of $17.57 million, a PE ratio of -0.18 and a beta of 1.63.
Institutional Investors Weigh In On Sientra
Several large investors have recently bought and sold shares of SIEN. Bank of Montreal Can lifted its position in shares of Sientra by 66.7% in the first quarter. Bank of Montreal Can now owns 66,589 shares of the medical instruments supplier’s stock valued at $151,000 after acquiring an additional 26,649 shares in the last quarter. HighTower Advisors LLC acquired a new stake in Sientra during the 1st quarter worth $101,000. Creative Planning purchased a new stake in shares of Sientra during the fourth quarter worth $55,000. Two Sigma Investments LP acquired a new stake in shares of Sientra in the fourth quarter valued at about $52,000. Finally, Atria Wealth Solutions Inc. grew its stake in Sientra by 1,512.9% during the 4th quarter. Atria Wealth Solutions Inc. now owns 250,000 shares of the medical instruments supplier’s stock valued at $51,000 after acquiring an additional 234,500 shares in the last quarter. 29.77% of the stock is currently owned by hedge funds and other institutional investors.
Sientra, Inc operates as a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices. It operates through the International and United States geographical segments. The company was founded by Hani M. Zeini on August 29, 2003 and is headquartered in Irvine, CA.
- Get a free copy of the StockNews.com research report on Sientra (SIEN)
- Ralph Lauren’s Styled Dividend Is Still In Season
- Dollar Tree Falls As Theft Cuts Into Bottom Line
- Best Buy’s Comeback Is Still At Play, Earnings Call For Patience
- e.l.f. Beauty Has Giant Quarter, Shares Hit New High
- If You Can Only Pick One Stock For The Rest Of 2023, Pick Nvidia
Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.